Torrent Pharmaceuticals Ltd. (TORNTPHARM) Share Price Rises 3.84% Today
- July 31, 2026
- Posted by: Harsh Piplani
- Category: News
Torrent Pharmaceuticals Ltd. Share Price rises 3.84% today, reaching Rs 5057.55 with a market cap of Rs 1,85,520.62 Cr.
Torrent Pharmaceuticals Ltd. Share Price has seen a notable rise today, increasing by 3.84% to reach Rs 5057.55. This significant movement places the company’s market capitalisation at Rs 1,85,520.62 crore, marking it as a key player in the Large Cap category.
The increase in Torrent Pharmaceuticals Ltd.’s share price today reflects a strong market interest, although the specific catalyst behind this rise is not detailed in the available data. The company’s performance in the healthcare sector, combined with its robust market presence, contributes to its appeal among investors. As the stock continues to gain momentum, it remains a focal point for those tracking share price movements in the pharmaceutical industry.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,057.55 |
| Previous Close | Rs 4,870.65 |
| Today's Change | +Rs 186.9 (+3.84%) |
| Day Open | Rs 4,969.1 |
| Day High | Rs 5,067.95 |
| Day Low | Rs 4,894.9 |
| Current Volume (BSE) | 2,76,088 |
| BSE Traded Volume | 2,76,088 |
| NSE Traded Volume | 7,01,274 |
| Combined NSE + BSE Volume | 9,77,362 |
| Turnover | Rs 139.63 crore |
| Market Capitalisation | Rs 1,85,520.62 crore |
| Market Cap Category | Large Cap |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) traded at Rs 5,057.55. versus the previous close of Rs 4,870.65, a rise of 3.84%. The stock opened at Rs 4,969.1, reached Rs 5,067.95, touched Rs 4,894.9. Reported volume was 2,76,088.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,85,520.62 crore |
Torrent Pharmaceuticals Ltd. boasts a market capitalisation of Rs 1,85,520.62 crore, positioning it as a major entity within the healthcare sector. The company’s valuation metrics, such as P/E and P/B ratios, are crucial for understanding its market standing.77, and the median P/B is 1.93, offering a context for comparison.
The healthcare sector, with 198 companies, presents a diverse landscape where Torrent Pharmaceuticals Ltd. competes. The sector’s average ROE and ROCE are 15.09% and 17.57%, respectively, indicating the profitability and efficiency standards within the industry. Torrent Pharmaceuticals Ltd.’s performance relative to these benchmarks can provide insights into its operational effectiveness and financial health.
While detailed earnings per share (EPS), book value, and dividend yield figures are not available, these metrics typically play a significant role in evaluating a company’s financial performance. Investors often look at these figures to assess the company’s profitability, asset value, and income distribution potential.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.77x |
| Benchmark Average P/E | 94.79x |
| Benchmark P/E Range | 3.3x to 3,417.8x |
| Benchmark Median P/B | 1.93x |
| Benchmark Median ROE | 10.74% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 1,85,520.62 crore |
| Benchmark Median Market Cap | Rs 140.91 crore |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Operating within the healthcare sector, Torrent Pharmaceuticals Ltd. is part of an industry characterized by innovation and regulatory dynamics. The sector’s benchmark data reveals a wide range of valuation metrics, with the P/E ratio spanning from 3.3 to 3417.8, reflecting the diverse nature of companies within this space.
With a median market capitalisation of Rs 140.91 crore among 198 companies, Torrent Pharmaceuticals Ltd.’s market cap of Rs 1,85,520.62 crore significantly exceeds the sector median, underscoring its substantial market presence. The company’s performance metrics, such as ROE and ROCE, are key indicators of its competitive standing within the sector.
As the healthcare industry continues to evolve, companies like Torrent Pharmaceuticals Ltd. must navigate challenges and opportunities presented by technological advancements, regulatory changes, and shifting consumer demands. The company’s ability to adapt and innovate will be crucial in maintaining its market leadership.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,950.66 | 0 | 0.75 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,726.18 | 0 | 2.23 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,700.98 | 39.17 | 7.93 | 28.21 | 26.35 |
| Panacea Biotec Ltd. | PANACEABIO | 2,598.26 | 0 | 8.89 | 0 | 5.36 |
| Beta Drugs Ltd. | BETA | 2,475.7 | 58.88 | 9.32 | 18.65 | 22.17 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a market capitalisation of Rs 1,85,520.62 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
In comparison to its peers, Torrent Pharmaceuticals Ltd. stands out with its substantial market capitalisation. Companies such as Dishman Carbogen Amcis Ltd. and Hikal Ltd. have market caps of Rs 2950.66 crore and Rs 2726.18 crore, respectively, highlighting Torrent Pharmaceuticals Ltd.’s dominant position.
While specific P/E, ROE, and ROCE values for Torrent Pharmaceuticals Ltd. are not provided, the peer group exhibits a range of performance metrics. For instance, Kwality Pharmaceuticals Ltd. has a P/E of 39.17 and an ROE of 28.21%, while Beta Drugs Ltd. shows a P/E of 58.88 and an ROE of 18.65%. These figures offer a benchmark for evaluating Torrent Pharmaceuticals Ltd.’s financial performance relative to its competitors.
Why Investors Are Watching Torrent Pharmaceuticals Ltd.
Investors are closely monitoring Torrent Pharmaceuticals Ltd. due to its recent price rise and strong market position. The company’s performance in the healthcare sector, coupled with its substantial market capitalisation, makes it a focal point for market participants.
- Price Action: The share price rose by 3.84% today, reaching Rs 5057.55.
- Technical Position: The stock’s price action indicates strong investor interest.
- Fundamental Context: The company’s market cap and sector benchmarks highlight its competitive standing.
- Sector Positioning: Torrent Pharmaceuticals Ltd. operates within a dynamic healthcare industry.
As the company continues to navigate the complexities of the healthcare sector, investors will be watching for further developments in its financial performance and market strategy.
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. is a leading player in the healthcare sector, specializing in the development and manufacturing of pharmaceutical products. The company operates across various segments, including branded and generic drugs, catering to a diverse range of therapeutic areas.
With a strong focus on research and development, Torrent Pharmaceuticals Ltd. aims to deliver innovative healthcare solutions that meet the evolving needs of patients and healthcare providers. The company’s extensive product portfolio and strategic market presence position it as a key player in the pharmaceutical industry.
As the healthcare landscape continues to change, Torrent Pharmaceuticals Ltd. remains committed to enhancing its product offerings and expanding its market reach, ensuring its continued growth and success in the industry.
Track Torrent Pharmaceuticals Ltd. Share Price on Univest
Use Torrent Pharmaceuticals Ltd. (TORNTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors can track Torrent Pharmaceuticals Ltd. Share Price and gain insights into its performance on Univest. The platform offers live updates on share price, technical indicators, fundamental ratios, and shareholding patterns. Additionally, users can explore 52-week levels and market insights to stay informed about the company’s market dynamics.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
How much did Torrent Pharmaceuticals Ltd. share price rise today?
Ans. The share price of Torrent Pharmaceuticals Ltd. rose by 3.84% today, reaching Rs 5057.55. The stock moved 3.84% during the session. The intraday range extended from Rs 4,894.9 to Rs 5,067.95.
How does Torrent Pharmaceuticals Ltd. compare to its peers?
Ans. Torrent Pharmaceuticals Ltd. has a substantial market cap compared to peers like Dishman Carbogen Amcis Ltd. and Hikal Ltd., highlighting its strong market position. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
What is the sector benchmark P/E for healthcare?
Ans. The sector benchmark median P/E for healthcare is 25.77, providing a context for evaluating company valuations. The relevant peer median P/E is 25.77x. The peer average P/E is 94.79x. The stock belongs to the Healthcare sector.
What is the sector benchmark ROE for healthcare?
Ans. The sector benchmark average ROE for healthcare is 15.09%, indicating the profitability standard within the industry. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%.
What is the current price of Torrent Pharmaceuticals Ltd.?
Ans. The current price of Torrent Pharmaceuticals Ltd. is Rs 5057.55, following a 3.84% rise today. The stock moved 3.84% during the session. The intraday range extended from Rs 4,894.9 to Rs 5,067.95.
